Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy
Summary: Despite advanced discoveries in cancerology, conventional treatments by surgery, chemotherapy, or radiotherapy remain ineffective in some situations. Oncolytic virotherapy, i.e., the involvement of replicative viruses targeting specific tumor cells, opens new perspectives for better management of this disease. Certain viruses naturally have a preferential tropism for the tumor cells; others are genetically modifiable to present such properties, as the lytic cycle virus, which is a process that represents a vital role in oncolytic virotherapy. In the present paper, we present a mathematical model for the dynamics of oncolytic virotherapy that incorporates multiple time delays representing the multiple time periods of a lytic cycle. We compute the basic reproductive ratio \(R_0\), and we show that there exist a disease-free equilibrium point (DFE) and an endemic equilibrium point (DEE). By formulating suitable Lyapunov function, we prove that the disease-free equilibrium (DFE) is globally asymptotically stable if \(R_0 < 1\) and unstable otherwise. We also demonstrate that under additional conditions, the endemic equilibrium is stable. Also, a Hopf bifurcation analysis of our dynamic system is used to understand how solutions and their stability change as system parameters change in the case of a positive delay. To illustrate the effectiveness of our theoretical results, we give numerical simulations for several scenarios.
- Mathematical analysis for oncolytic virotherapy
- Hopf-bifurcation analysis of a delayed model for the treatment of cancer using virotherapy
- Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response
- Dynamical behavior of a new oncolytic virotherapy model based on gene variation
- A mathematical model for cell cycle-specific cancer virotherapy
- A mathematical model for cell cycle-specific cancer virotherapy
- A mathematical model of oncolytic virotherapy with time delay
- Analysis of a model of a virus that replicates selectively in tumor cells
- Computational modeling approaches to studying the dynamics of oncolytic viruses
- Hopf bifurcation analysis in a delayed system for cancer virotherapy
- scientific article; zbMATH DE number 2150813 (Why is no real title available?)
- Lytic cycle: A defining process in oncolytic virotherapy
- Modeling and analysis of a virus that replicates selectively in tumor cells
- Modeling of cancer virotherapy with recombinant measles viruses
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- A mathematical approach to effects of CTLs on cancer virotherapy in the second injection of virus
- Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy
- Combination of virotherapy and chemotherapy with optimal control for combating cancer
- A mathematical model of oncolytic virotherapy with time delay
- A mathematical model for tumor growth and treatment using virotherapy
- Analysis of a delayed and diffusive oncolytic M1 virotherapy model with immune response
- Dynamics of a virological model for cancer therapy with innate immune response
- Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response
- Dynamical behavior of a new oncolytic virotherapy model based on gene variation
- A mathematical model for cell cycle-specific cancer virotherapy
- Lytic cycle: A defining process in oncolytic virotherapy
- Mathematical analysis for oncolytic virotherapy
- Hopf-bifurcation analysis of a delayed model for the treatment of cancer using virotherapy
- Modeling treatment of cancer using oncolytic virotherapy with saturated incidence
- Bifurcation analysis of the cancer virotherapy system with time delay and diffusion
- On the dynamics and optimal control of a mathematical model of neuroblastoma and its treatment: insights from a mathematical model
- Hybrid fractional derivative for modeling and analysis of cancer treatment with virotherapy
This page was built for publication: Analysis of a multiple delays model for treatment of cancer with oncolytic virotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2332518)
